For Media Inquiries, Please Contact:
Global Corporate Communications
1 (416) 749-9026 Ext. 7487
September 25, 2019Apotex Corp. Issues Voluntary Nationwide Recall of Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) due to the potential for Detection of an Amount of Unexpected Impurity,N-nitrosodimethylamine (NDMA) Impurity in the product
March 1, 2019Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 blister pack/carton due to possibility of missing/incorrect tablet arrangement
May 31, 2018Apotex Corp. Issues Voluntary Nationwide Recall of Fluticasone Propionate Nasal Spray USP 50 mcg per spray 120 Metered Sprays due to potential for small glass particles
May 14, 2018Apotex Corp. Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam for Injection, USP 3.375 gram/vial and 4.5 gram/vial Strengths due to Elevated Levels of Impurities that may Result in Decreased Potency.